PDS Biotechnology Corporation (PDSB) Social Stream



PDS Biotechnology Corporation (PDSB): $5.15

0.59 (+12.94%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PDSB to Watchlist
Sign Up

Industry: Biotech


Ranked

of 389

in industry

PDS Biotechnology Corp (PDSB) Price Targets From Analysts

Use the tables below to see what analysts covering PDS Biotechnology Corp think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-03-17 5 $25 $15 $20.4 $6.29 224.32%

The Trend in the Analyst Price Target


PDSB's average price target has moved up $12.38 over the prior 51 weeks.

Over the past 48 weeks, PDSB's average upside potential has been 83.21%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-19 5 12 6.5 8.35 5.74 45.47%
2021-06-05 5 20 6.5 10.52 12.78 -17.68%
2021-07-10 5 25 14.0 19.14 10.76 77.88%
2021-10-22 7 25 15.0 20.40 11.66 74.96%
2021-10-22 5 25 15.0 20.40 11.66 74.96%

PDSB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


Over the past 48 weeks, PDSB's average broker recommendation rating improved by 0.8.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how PDS Biotechnology Corp fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 89.53% of that group.
  • In terms of how PDS Biotechnology Corp fares relative to Healthcare stocks, note that its average analyst price target is greater than 33.57% of that group.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, PDS Biotechnology Corp's variance in analysts' estimates is lower than 34.08% of them.
  • In the context of stocks in the small market cap category, PDS Biotechnology Corp's number of analysts covering the stock is higher than 64.09% of them.

In the Pharmaceutical Products industry, OVID, OTIC, and ORPH are the three stocks most similar to PDS Biotechnology Corp regarding the price target and analyst recommendation information presented here.

What is the outlook for PDSB? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.1325 seconds.